Jessica Ailani

5.1k total citations · 5 hit papers
120 papers, 3.3k citations indexed

About

Jessica Ailani is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Jessica Ailani has authored 120 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Psychiatry and Mental health, 62 papers in Pathology and Forensic Medicine and 31 papers in Physiology. Recurrent topics in Jessica Ailani's work include Migraine and Headache Studies (112 papers), Trigeminal Neuralgia and Treatments (52 papers) and Sympathectomy and Hyperhidrosis Treatments (29 papers). Jessica Ailani is often cited by papers focused on Migraine and Headache Studies (112 papers), Trigeminal Neuralgia and Treatments (52 papers) and Sympathectomy and Hyperhidrosis Treatments (29 papers). Jessica Ailani collaborates with scholars based in United States, United Kingdom and Denmark. Jessica Ailani's co-authors include David W. Dodick, Joel M. Trugman, Richard B. Lipton, Matthew S. Robbins, Michelle Finnegan, Rebecca Burch, Kaifeng Lu, Armin Szegedi, Qi Zhang and Robert R. Conley and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jessica Ailani

108 papers receiving 3.2k citations

Hit Papers

The American Headache Society Consensus Statement... 2018 2026 2020 2023 2021 2018 2019 2021 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
    2021 433 citations Jessica Ailani et al. Headache The Journal of Head and Face Pain profile →
  2. Evaluation of Galcanezumab for the Prevention of Episodic Migraine
    2018 408 citations David W. Dodick, Jessica Ailani et al. profile →
  3. Ubrogepant for the Treatment of Migraine
    2019 253 citations David W. Dodick, Richard B. Lipton et al. profile →
  4. Atogepant for the Preventive Treatment of Migraine
    2021 194 citations Jessica Ailani, Richard B. Lipton et al. profile →
  5. Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
    2023 75 citations Patricia Pozo‐Rosich, Jessica Ailani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica Ailani United States 27 2.9k 1.8k 1.0k 388 378 120 3.3k
Christian Lampl Austria 26 2.4k 0.8× 1.4k 0.8× 857 0.8× 444 1.1× 272 0.7× 69 3.0k
David Kudrow United States 26 2.5k 0.9× 1.8k 1.0× 1.1k 1.0× 275 0.7× 298 0.8× 65 2.8k
Sepideh F. Varon United States 27 3.1k 1.1× 2.0k 1.1× 885 0.8× 510 1.3× 209 0.6× 38 3.6k
Stephen D. Silberstein United States 28 2.9k 1.0× 1.7k 0.9× 1.1k 1.0× 237 0.6× 307 0.8× 58 3.2k
Andrew Blumenfeld United States 35 3.3k 1.2× 2.3k 1.2× 1.4k 1.4× 958 2.5× 227 0.6× 126 4.0k
Miguel J. A. Láinez Spain 28 2.2k 0.8× 1.5k 0.8× 923 0.9× 341 0.9× 302 0.8× 69 2.7k
Raffaele Ornello Italy 29 2.1k 0.7× 1.1k 0.6× 579 0.6× 519 1.3× 375 1.0× 112 3.0k
Frederick G. Freitag United States 18 3.0k 1.1× 1.8k 1.0× 1.2k 1.1× 266 0.7× 239 0.6× 65 3.3k
ME Bigal United States 28 2.4k 0.9× 1.4k 0.8× 906 0.9× 342 0.9× 291 0.8× 46 2.8k
RB Lipton United States 13 2.5k 0.9× 1.5k 0.8× 992 0.9× 197 0.5× 193 0.5× 28 2.8k

Countries citing papers authored by Jessica Ailani

Since Specialization
Citations

This map shows the geographic impact of Jessica Ailani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Ailani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Ailani more than expected).

Fields of papers citing papers by Jessica Ailani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Ailani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Ailani. The network helps show where Jessica Ailani may publish in the future.

Co-authorship network of co-authors of Jessica Ailani

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Ailani. A scholar is included among the top collaborators of Jessica Ailani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Ailani. Jessica Ailani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terwindt, Gisela M., Jessica Ailani, Lucy Abraham, et al.. (2025). Underdiagnosis and impact of menstrual migraine in real‐world clinical practice: A real‐world survey. Headache The Journal of Head and Face Pain. 65(8). 1413–1427.
2.
3.
Charles, Andrew, Stewart J. Tepper, & Jessica Ailani. (2025). State of the art in the management of migraine—A response to the American College of Physicians migraine preventive treatment guideline. Headache The Journal of Head and Face Pain. 65(9). 1653–1656.
4.
Ailani, Jessica, Richard Lipton, Andrew Blumenfeld, et al.. (2024). Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study. Headache The Journal of Head and Face Pain. 65(6). 1005–1014. 4 indexed citations
5.
Ailani, Jessica, Pranav Gandhi, Amber Trujillo Lalla, et al.. (2024). Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine. Headache The Journal of Head and Face Pain. 64(10). 1253–1263. 2 indexed citations
6.
Thomas, Davis C., Junad Khan, Daniele Manfredini, & Jessica Ailani. (2023). Temporomandibular Joint Disorder Comorbidities. Dental Clinics of North America. 67(2). 379–392. 17 indexed citations
7.
Raffaelli, Bianca, et al.. (2023). Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review. Cephalalgia. 43(2). 2205182147–2205182147. 11 indexed citations
8.
Pozo‐Rosich, Patricia, Jessica Ailani, Messoud Ashina, et al.. (2023). Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial (S47.005). Neurology. 100(17_supplement_2). 4 indexed citations
9.
Blumenfeld, Andrew, et al.. (2023). Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine. Headache The Journal of Head and Face Pain. 63(3). 322–332. 12 indexed citations
10.
Ashina, Messoud, Richard B. Lipton, Jessica Ailani, et al.. (2023). Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial. European Journal of Neurology. 31(2). e16131–e16131. 4 indexed citations
11.
12.
Goadsby, Peter J., Jessica Ailani, David W. Dodick, et al.. (2023). Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): Results from the prodrome trial. Journal of the Neurological Sciences. 455. 121630–121630. 3 indexed citations
13.
Ailani, Jessica, et al.. (2023). The Safety of Celecoxib as an Acute Treatment for Migraine: A Narrative Review. Pain and Therapy. 12(3). 655–669. 6 indexed citations
14.
MacGregor, E. Anne, et al.. (2023). Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysis. Headache The Journal of Head and Face Pain. 63(8). 1135–1144. 4 indexed citations
15.
Tepper, Stewart J., Huma U. Sheikh, Stephanie J. Nahas, et al.. (2022). Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations. Headache The Journal of Head and Face Pain. 62(4). 420–435. 8 indexed citations
16.
Clemow, David B., Helen Hochstetler, Yanhong Dong, et al.. (2021). Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine. Postgraduate Medicine. 133(4). 449–459. 4 indexed citations
17.
Hutchinson, Susan, Richard B. Lipton, Jessica Ailani, et al.. (2020). Characterization of Acute Prescription Migraine Medication Use. Mayo Clinic Proceedings. 95(4). 709–718. 21 indexed citations
18.
Ailani, Jessica, et al.. (2019). A Review of Spontaneous Intracranial Hypotension. Current Neurology and Neuroscience Reports. 19(5). 22–22. 19 indexed citations
19.
Ailani, Jessica, et al.. (2019). Traditional and Novel Migraine Therapy in the Aging Population. Current Pain and Headache Reports. 23(6). 42–42. 5 indexed citations
20.
Ailani, Jessica. (2009). Chronic tension-type headache. Current Pain and Headache Reports. 13(6). 479–483. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Lampl Breakdown of academic impact, for papers by David Kudrow Breakdown of academic impact, for papers by Sepideh F. Varon Breakdown of academic impact, for papers by Stephen D. Silberstein Breakdown of academic impact, for papers by Andrew Blumenfeld Breakdown of academic impact, for papers by Miguel J. A. Láinez Breakdown of academic impact, for papers by Raffaele Ornello Breakdown of academic impact, for papers by Frederick G. Freitag Breakdown of academic impact, for papers by ME Bigal Breakdown of academic impact, for papers by RB Lipton
Rankless by CCL
2026